Introduction Symptoms associated with SARS-CoV-2 infection remain incompletely understood, especially among ambulatory, non-hospitalized individuals. With host factors, symptoms predictive of SARS-CoV-2 could be used to guide testing and intervention strategies. Methods Between March 16 and September 3, 2020, we examined the characteristics and symptoms reported by individuals presenting to a large outpatient testing program in the Southeastern US for nasopharyngeal SARS-CoV-2 RNA RT-PCR testing. Using self-reported symptoms, demographic characteristics, and exposure and travel histories, we identified the variables associated with testing positive using modified Poisson regression. Results Among 20,177 tested individuals, the proportion po...
This study aimed to estimate the diagnostic performance of patient symptoms and to describe the clin...
A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a smartphone-base...
Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antib...
Introduction Symptoms associated with SARS-CoV-2 infection remain incompletely understood, especiall...
BACKGROUND: “Classic” symptoms (cough, fever, loss of taste/smell) prompt severe acute respiratory...
BackgroundCoronavirus 2019 disease (COVID-19) is caused by the virus SARS-CoV-2, transmissible both ...
Background: Rapid detection, isolation and contact tracing of community COVID-19 cases are essential...
BACKGROUND: Prior studies examining symptoms of COVID-19 are primarily descriptive and measured amon...
Background: Multiple voluntary surveillance platforms were developed across the world in response t...
BACKGROUND: Coronavirus 2019 disease (COVID-19) is caused by the virus SARS-CoV-2, transmissible bot...
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectious virus isolation in ...
This study aimed to estimate the diagnostic performance of patient symptoms and to describe the clin...
Background: Limited data exist on early predictive clinical symptoms or combinations of symptoms tha...
Background: SARS-CoV-2 infection among People Living With HIV (PLWH) is not well-described. Objectiv...
BackgroundPrior studies examining symptoms of COVID-19 are primarily descriptive and measured among ...
This study aimed to estimate the diagnostic performance of patient symptoms and to describe the clin...
A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a smartphone-base...
Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antib...
Introduction Symptoms associated with SARS-CoV-2 infection remain incompletely understood, especiall...
BACKGROUND: “Classic” symptoms (cough, fever, loss of taste/smell) prompt severe acute respiratory...
BackgroundCoronavirus 2019 disease (COVID-19) is caused by the virus SARS-CoV-2, transmissible both ...
Background: Rapid detection, isolation and contact tracing of community COVID-19 cases are essential...
BACKGROUND: Prior studies examining symptoms of COVID-19 are primarily descriptive and measured amon...
Background: Multiple voluntary surveillance platforms were developed across the world in response t...
BACKGROUND: Coronavirus 2019 disease (COVID-19) is caused by the virus SARS-CoV-2, transmissible bot...
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectious virus isolation in ...
This study aimed to estimate the diagnostic performance of patient symptoms and to describe the clin...
Background: Limited data exist on early predictive clinical symptoms or combinations of symptoms tha...
Background: SARS-CoV-2 infection among People Living With HIV (PLWH) is not well-described. Objectiv...
BackgroundPrior studies examining symptoms of COVID-19 are primarily descriptive and measured among ...
This study aimed to estimate the diagnostic performance of patient symptoms and to describe the clin...
A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a smartphone-base...
Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antib...